Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

ClinicalTrials.gov ID: NCT06034743

Public ClinicalTrials.gov record NCT06034743. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 12:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

Study identification

NCT ID
NCT06034743
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
796 participants

Conditions and interventions

Interventions

  • Baxdrostat Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 21, 2023
Primary completion
May 20, 2025
Completion
Oct 9, 2025
Last update posted
Nov 9, 2025

2023 – 2025

United States locations

U.S. sites
43
U.S. states
24
U.S. cities
41
Facility City State ZIP Site status
Research Site Saraland Alabama 36571
Research Site Scottsdale Arizona 85054
Research Site Sun City West Arizona 85375
Research Site Surprise Arizona 85374
Research Site Little Rock Arkansas 72211
Research Site Fresno California 93720
Research Site Lincoln California 95648
Research Site Orange California 92868
Research Site Rancho Cucamonga California 91730
Research Site Stanford California 94304
Research Site New Haven Connecticut 06510
Research Site Clearwater Florida 33765
Research Site Jacksonville Florida 32204
Research Site Port Orange Florida 32127
Research Site Atlanta Georgia 30344
Research Site Decatur Georgia 30033
Research Site Springfield Illinois 62702
Research Site Munster Indiana 46321
Research Site Lexington Kentucky 40503
Research Site Detroit Michigan 48202
Research Site Rochester Minnesota 55905
Research Site Olive Branch Mississippi 38654
Research Site Kansas City Missouri 64111
Research Site Kansas City Missouri 64128
Research Site Kansas City Missouri 64151
Research Site Rosedale New York 11422
Research Site The Bronx New York 10455
Research Site Chapel Hill North Carolina 27599
Research Site New Bern North Carolina 28562
Research Site Toledo Ohio 43614
Research Site Grants Pass Oregon 97527
Research Site Bethlehem Pennsylvania 18017
Research Site Langhorne Pennsylvania 19047
Research Site East Providence Rhode Island 02914
Research Site Memphis Tennessee 38105
Research Site Brownsville Texas 78526
Research Site Corpus Christi Texas 78404
Research Site Houston Texas 77054
Research Site Sugar Land Texas 77479
Research Site Manassas Virginia 20110
Research Site Suffolk Virginia 23435
Research Site Madison Wisconsin 53792
Research Site Milwaukee Wisconsin 53295

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 220 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06034743, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 9, 2025 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06034743 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →